{"Bempedoic": [0, 296], "acid,": [1, 80, 349], "an": [2], "ATP": [3], "citrate": [4], "lyase": [5], "inhibitor,": [6], "reduces": [7], "low-density": [8], "lipoprotein": [9], "(LDL)": [10], "cholesterol": [11, 145], "levels": [12], "and": [13, 62, 128, 157, 279, 311, 320, 333, 350, 397], "is": [14], "associated": [15, 361], "with": [16, 168, 172, 205, 209, 324, 328, 357, 362], "a": [17, 32, 40, 91, 198, 233, 363], "low": [18], "incidence": [19, 196], "of": [20, 34, 94, 115, 137, 192, 197, 232, 235, 318, 342, 366], "muscle-related": [21], "adverse": [22, 58, 96, 368], "events;": [23], "its": [24], "effects": [25, 59, 301], "on": [26, 302], "cardiovascular": [27, 70, 97, 103, 238, 309, 369, 373], "outcomes": [28], "remain": [29], "uncertain.": [30], "Download": [31], "PDF": [33], "the": [35, 124, 131, 161, 164, 179, 183, 230, 340], "Research": [36], "Summary.": [37], "We": [38], "conducted": [39], "double-blind,": [41], "randomized,": [42], "placebo-controlled": [43], "trial": [44], "involving": [45], "patients": [46, 73, 117, 212], "who": [47], "were": [48, 65, 74, 121, 229, 322, 339], "unable": [49], "or": [50, 64, 84, 110, 242, 261, 304, 380], "unwilling": [51], "to": [52, 56, 76, 123, 130, 225, 257, 276, 293], "take": [53], "statins": [54], "owing": [55], "unacceptable": [57], "(\"statin-intolerant\"": [60], "patients)": [61], "had,": [63], "at": [66, 147], "high": [67], "risk": [68, 365], "for,": [69], "disease.": [71], "The": [72, 86, 134, 142, 195, 316], "assigned": [75, 122], "receive": [77], "oral": [78], "bempedoic": [79, 125, 169, 193, 206, 325, 358], "180": [81], "mg": [82, 151, 176], "daily,": [83], "placebo.": [85], "primary": [87, 199], "end": [88], "point": [89], "was": [90, 139, 149, 166, 186, 202, 360], "four-component": [92], "composite": [93, 234], "major": [95, 367], "events,": [98], "defined": [99], "as": [100, 228, 338], "death": [101, 236, 307, 312], "from": [102, 237, 308, 313, 372], "causes,": [104, 239, 310, 374], "nonfatal": [105, 108, 240, 243, 262, 305, 375, 378], "myocardial": [106, 244, 263, 376], "infarction,": [107, 377], "stroke,": [109, 241, 306, 379], "coronary": [111, 280, 381], "revascularization.": [112], "A": [113], "total": [114], "13,970": [116], "underwent": [118], "randomization;": [119], "6992": [120], "acid": [126, 170, 207, 297, 326, 359], "group": [127], "6978": [129], "placebo": [132, 173, 210, 329], "group.": [133], "median": [135], "duration": [136], "follow-up": [138], "40.6": [140], "months.": [141], "mean": [143], "LDL": [144], "level": [146, 165], "baseline": [148], "139.0": [150], "per": [152, 177], "deciliter": [153], "in": [154, 163, 182, 190, 345], "both": [155], "groups,": [156], "after": [158], "6": [159], "months,": [160], "reduction": [162], "greater": [167], "than": [171, 208, 327], "by": [174, 384], "29.2": [175], "deciliter;": [178], "observed": [180], "difference": [181], "percent": [184], "reductions": [185], "21.1": [187], "percentage": [188], "points": [189], "favor": [191], "acid.": [194], "end-point": [200], "event": [201], "significantly": [203], "lower": [204, 364], "(819": [211], "[11.7%]": [213], "vs.": [214, 248, 267, 284, 331, 335], "927": [215], "[13.3%];": [216], "hazard": [217, 251, 270, 287], "ratio,": [218, 252, 271, 288], "0.87;": [219], "95%": [220, 254, 273, 290], "confidence": [221], "interval": [222], "[CI],": [223], "0.79": [224], "0.96;": [226, 258], "P=0.004),": [227], "incidences": [231, 317, 341], "infarction": [245, 264], "(575": [246], "[8.2%]": [247], "663": [249], "[9.5%];": [250], "0.85;": [253], "CI,": [255, 274, 291], "0.76": [256], "P=0.006);": [259], "fatal": [260, 303], "(261": [265], "[3.7%]": [266], "334": [268], "[4.8%];": [269], "0.77;": [272], "0.66": [275], "0.91;": [277], "P=0.002);": [278], "revascularization": [281], "(435": [282], "[6.2%]": [283], "529": [285], "[7.6%];": [286], "0.81;": [289], "0.72": [292], "0.92;": [294], "P=0.001).": [295], "had": [298], "no": [299], "significant": [300], "any": [314], "cause.": [315], "gout": [319], "cholelithiasis": [321], "higher": [323], "(3.1%": [330], "2.1%": [332], "2.2%": [334], "1.2%,": [336], "respectively),": [337], "small": [343], "increases": [344], "serum": [346], "creatinine,": [347], "uric": [348], "hepatic-enzyme": [351], "levels.": [352], "Among": [353], "statin-intolerant": [354], "patients,": [355], "treatment": [356], "events": [370], "(death": [371], "revascularization).": [382], "(Funded": [383], "Esperion": [385], "Therapeutics;": [386], "CLEAR": [387], "Outcomes": [388, 399], "ClinicalTrials.gov": [389], "number,": [390], "NCT02993406.)": [391], "QUICK": [392], "TAKE": [393], "VIDEO": [394], "SUMMARYBempedoic": [395], "Acid": [396], "Cardiovascular": [398], "02:22": [400]}